ESR1 and breast carcinoma: The possible mechanism for inhibition of the PI3K/AKT pathway and enhancement of breast cancer cell apoptosis by ER modulators (e.g., equol, biochanin A, daidzein) could be related to PRODH/POX-dependent ROS generation.